Skip to content

Clinical trials

Active, not recruiting Leukemia, Myelomonocytic, Chronic trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelomonocytic, Chronic Status: Active, not recruiting Country / region: United States Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20092
20101
20121
20141
20161
20182
20195
20202
20217
20225
20235

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting33

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center6
National Cancer Institute (NCI)6
City of Hope Medical Center3
Novartis Pharmaceuticals2
AbbVie1
Barbara Ann Karmanos Cancer Institute1
Center for International Blood and Marrow Transplant Research1
Dana-Farber Cancer Institute1
Eli Lilly and Company1
Faron Pharmaceuticals Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelomonocytic, Chronic33
Myelodysplastic Syndromes25
Leukemia, Myeloid, Acute16
Myeloproliferative Disorders13
Primary Myelofibrosis10
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative5
Polycythemia Vera5
Thrombocythemia, Essential5
Hematologic Neoplasms4
Leukemia4

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.